FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / J Equine Sci / The combination of BMP12 and KY02111 enhances tendon differe...
Journal of equine science2022; 33(2); 19-26; doi: 10.1294/jes.33.19

The combination of BMP12 and KY02111 enhances tendon differentiation in bone marrow-derived equine mesenchymal stromal cells (BM-eMSCs).

Abstract: The Wingless and Int-1 (WNT) and bone morphogenic protein/growth differentiation factor (BMP/GDF) signalling pathways contribute significantly to the development of the musculoskeletal system. The mechanism by which they contribute is as follows: BMP/GDF signalling usually promotes tendon differentiation, whereas WNT signalling inhibits it. We hypothesised that inhibiting WNT and subsequently stimulating BMP signalling may enhance the tenogenic differentiation of stem cells. The objective of this study was to determine whether a combination of WNT inhibitor (KY02111) and BMP12/GDF7 protein could enhance the differentiation of bone marrow-derived equine mesenchymal stromal cells (BM-eMSCs) into tenocytes. Cells were cultured in five treatments: control, BMP12, and three different combinations of BMP12 and KY02111. The results indicated that a 1-day treatment with KY02111 followed by a 13-day treatment with BMP12 resulted in the highest tenogenic differentiation score in this experiment. The effect of KY02111 is dependent on the incubation time, with 1 day being better than 3 or 5 days. This combination increased tenogenic gene marker expression, including SCX, TNMD, DCN, and TNC, as well as COL1 protein expression. In conclusion, we propose that a combination of BMP12 and KY02111 can enhance the in vitro tenogenic differentiation of BM-eMSCs more than BMP12 alone. The findings of this study might be useful for improving tendon differentiation protocols for stem cell transplantation and application to tendon regeneration.
©2022 The Japanese Society of Equine Science.
Get Full Text
Publication Date: 2022-07-06 PubMed ID: 35847484PubMed Central: PMC9260033DOI: 10.1294/jes.33.19Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research examines the interaction of bone morphogenic protein 12 (BMP12) and Wingless and Int-1 inhibitor (KY02111) on equine stem cells, concluding that their combined use enhances the cells’ ability to differentiate into tendon cells.

Research Objectives

The objectives of the research involved investigation of the interaction between of BMP12 and KY02111 towards the differentiation of bone marrow-derived equine mesenchymal stromal cells (BM-eMSCs) into tenocytes, or tendon cells. The hypothesis was that suppressing the WNT pathway (using WNT inhibitor KY02111) and stimulating the BMP signalling would promote this differentiation.

Methodology

  • Equine stem cells were subjected to five different treatments: a control group, BMP12 alone, and three combinations of BMP12 and KY02111.
  • Within the combination groups, the treatment varied based on the length of exposure to KY02111 (WNT inhibitor) followed by BMP12.
  • The researchers analyzed the tenogenic differentiation (transformation into tendon cells), looking particularly at gene markers such as SCX, TNMD, DCN, TNC, and COL1 protein expression.

Findings

  • The results revealed that a one-day exposure to KY02111 followed by a 13-day exposure to BMP12 led to the highest rates of tenogenic differentiation. Longer occurrences of exposure to KY02111 (3 or 5 days) were found to be less effective.
  • The researchers noticed an increase in tenogenic gene marker expression, implying a tendency toward tendon cell formation in the groups that were exposed to KY02111 before BMP12.

Conclusion

  • The study found that the combined use of BMP12 and KY02111 had more potential in fostering the differentiation of equine stem cells into tendon cells compared to using BMP12 alone.
  • As a result, the research suggested that these findings could be important for developing improved methods for tendon regeneration utilizing stem cell transplantation, particularly in medical and veterinary practices.

Cite This Article

APA
Supokawej A, Korchunjit W, Wongtawan T. (2022). The combination of BMP12 and KY02111 enhances tendon differentiation in bone marrow-derived equine mesenchymal stromal cells (BM-eMSCs). J Equine Sci, 33(2), 19-26. https://doi.org/10.1294/jes.33.19

Publication

Journal of equine science
ISSN: 1340-3516
NlmUniqueID: 9503751
Country: Japan
Language: English
Volume: 33
Issue: 2
Pages: 19-26

Researcher Affiliations

Supokawej, Aungkura
  • Department of Clinical Microscopy, Faculty of Medical Technology, Mahidol University, Nakhon Pathom 73170, Thailand.
Korchunjit, Wasamon
  • Department of Clinical Microscopy, Faculty of Medical Technology, Mahidol University, Nakhon Pathom 73170, Thailand.
  • Laboratory of Cellular Biomedicine, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom 73170, Thailand.
Wongtawan, Tuempong
  • Akkhararatchakumari Veterinary College, Walailak University, Nakhon Si Thammarat 80160, Thailand.
  • Centre for One Health, Walailak University, Nakhon Si Thammarat 80160, Thailand.
  • Laboratory of Cellular Biomedicine, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom 73170, Thailand.

References

This article includes 45 references
  1. Ahrberg AB, Horstmeier C, Berner D, Brehm W, Gittel C, Hillmann A, Josten C, Rossi G, Schubert S, Winter K, Burk J. Effects of mesenchymal stromal cells versus serum on tendon healing in a controlled experimental trial in an equine model.. BMC Musculoskelet Disord 2018 Jul 18;19(1):230.
    pmc: PMC6052633pubmed: 30021608doi: 10.1186/s12891-018-2163-ygoogle scholar: lookup
  2. Alves AG, Stewart AA, Dudhia J, Kasashima Y, Goodship AE, Smith RK. Cell-based therapies for tendon and ligament injuries.. Vet Clin North Am Equine Pract 2011 Aug;27(2):315-33.
    pubmed: 21872761doi: 10.1016/j.cveq.2011.06.001google scholar: lookup
  3. Arai HN, Sato F, Yamamoto T, Woltjen K, Kiyonari H, Yoshimoto Y, Shukunami C, Akiyama H, Kist R, Sehara-Fujisawa A. Metalloprotease-Dependent Attenuation of BMP Signaling Restricts Cardiac Neural Crest Cell Fate.. Cell Rep 2019 Oct 15;29(3):603-616.e5.
    pubmed: 31618630doi: 10.1016/j.celrep.2019.09.019google scholar: lookup
  4. Barlian A, Judawisastra H, Alfarafisa NM, Wibowo UA, Rosadi I. Chondrogenic differentiation of adipose-derived mesenchymal stem cells induced by L-ascorbic acid and platelet rich plasma on silk fibroin scaffold.. PeerJ 2018;6:e5809.
    pmc: PMC6250097pubmed: 30488014doi: 10.7717/peerj.5809google scholar: lookup
  5. Basson MA. Signaling in cell differentiation and morphogenesis.. Cold Spring Harb Perspect Biol 2012 Jun 1;4(6).
    pmc: PMC3367549pubmed: 22570373doi: 10.1101/cshperspect.a008151google scholar: lookup
  6. Beerts C, Suls M, Broeckx SY, Seys B, Vandenberghe A, Declercq J, Duchateau L, Vidal MA, Spaas JH. Tenogenically Induced Allogeneic Peripheral Blood Mesenchymal Stem Cells in Allogeneic Platelet-Rich Plasma: 2-Year Follow-up after Tendon or Ligament Treatment in Horses.. Front Vet Sci 2017;4:158.
    pmc: PMC5622984pubmed: 29018808doi: 10.3389/fvets.2017.00158google scholar: lookup
  7. Blake JA, Ziman MR. Pax genes: regulators of lineage specification and progenitor cell maintenance.. Development 2014 Feb;141(4):737-51.
    pubmed: 24496612doi: 10.1242/dev.091785google scholar: lookup
  8. Broeckx SY, Spaas JH, Chiers K, Duchateau L, Van Hecke L, Van Brantegem L, Dumoulin M, Martens AM, Pille F. Equine allogeneic chondrogenic induced mesenchymal stem cells: A GCP target animal safety and biodistribution study.. Res Vet Sci 2018 Apr;117:246-254.
    pubmed: 29329028doi: 10.1016/j.rvsc.2017.12.018google scholar: lookup
  9. Costa-Almeida R, Calejo I, Gomes ME. Mesenchymal Stem Cells Empowering Tendon Regenerative Therapies.. Int J Mol Sci 2019 Jun 19;20(12).
    pmc: PMC6627139pubmed: 31248196doi: 10.3390/ijms20123002google scholar: lookup
  10. Derfoul A, Perkins GL, Hall DJ, Tuan RS. Glucocorticoids promote chondrogenic differentiation of adult human mesenchymal stem cells by enhancing expression of cartilage extracellular matrix genes.. Stem Cells 2006 Jun;24(6):1487-95.
    pubmed: 16469821doi: 10.1634/stemcells.2005-0415google scholar: lookup
  11. Deshmukh V, Seo T, O'Green AL, Ibanez M, Hofilena B, Kc S, Stewart J, Dellamary L, Chiu K, Ghias A, Barroga C, Kennedy S, Tambiah J, Hood J, Yazici Y. SM04755, a small-molecule inhibitor of the Wnt pathway, as a potential topical treatment for tendinopathy.. J Orthop Res 2021 Sep;39(9):2048-2061.
    pmc: PMC8451793pubmed: 33104243doi: 10.1002/jor.24898google scholar: lookup
  12. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon.. Equine Vet J 2012 Jan;44(1):25-32.
    pubmed: 21615465doi: 10.1111/j.2042-3306.2011.00363.xgoogle scholar: lookup
  13. Gugjoo MB, Amarpal, Makhdoomi DM, Sharma GT. Equine Mesenchymal Stem Cells: Properties, Sources, Characterization, and Potential Therapeutic Applications.. J Equine Vet Sci 2019 Jan;72:16-27.
    pubmed: 30929778doi: 10.1016/j.jevs.2018.10.007google scholar: lookup
  14. Huang X, Zhong L, Hendriks J, Post JN, Karperien M. The Effects of the WNT-Signaling Modulators BIO and PKF118-310 on the Chondrogenic Differentiation of Human Mesenchymal Stem Cells.. Int J Mol Sci 2018 Feb 13;19(2).
    pmc: PMC5855783pubmed: 29438298doi: 10.3390/ijms19020561google scholar: lookup
  15. Jelinsky SA, Li L, Ellis D, Archambault J, Li J, St Andre M, Morris C, Seeherman H. Treatment with rhBMP12 or rhBMP13 increase the rate and the quality of rat Achilles tendon repair.. J Orthop Res 2011 Oct;29(10):1604-12.
    pubmed: 21469182doi: 10.1002/jor.21427google scholar: lookup
  16. Kim JH, Liu X, Wang J, Chen X, Zhang H, Kim SH, Cui J, Li R, Zhang W, Kong Y, Zhang J, Shui W, Lamplot J, Rogers MR, Zhao C, Wang N, Rajan P, Tomal J, Statz J, Wu N, Luu HH, Haydon RC, He TC. Wnt signaling in bone formation and its therapeutic potential for bone diseases.. Ther Adv Musculoskelet Dis 2013 Feb;5(1):13-31.
    pmc: PMC3582304pubmed: 23514963doi: 10.1177/1759720x12466608google scholar: lookup
  17. Kishimoto Y, Ohkawara B, Sakai T, Ito M, Masuda A, Ishiguro N, Shukunami C, Docheva D, Ohno K. Wnt/β-catenin signaling suppresses expressions of Scx, Mkx, and Tnmd in tendon-derived cells.. PLoS One 2017;12(7):e0182051.
    pmc: PMC5531628pubmed: 28750046doi: 10.1371/journal.pone.0182051google scholar: lookup
  18. Korchunjit W, Laikul A, Taylor J, Watchrarat K, Ritruechai P, Supokawej A, Wongtawan T. Characterization and allogeneic transplantation of equine bone marrow-derived multipotent mesenchymal stromal cells collected from cadavers. J. Equine Vet. Sci. 2019;73:15–23.
  19. Kusuma GD, Menicanin D, Gronthos S, Manuelpillai U, Abumaree MH, Pertile MD, Brennecke SP, Kalionis B. Ectopic Bone Formation by Mesenchymal Stem Cells Derived from Human Term Placenta and the Decidua.. PLoS One 2015;10(10):e0141246.
    pmc: PMC4618923pubmed: 26484666doi: 10.1371/journal.pone.0141246google scholar: lookup
  20. Lee JY, Zhou Z, Taub PJ, Ramcharan M, Li Y, Akinbiyi T, Maharam ER, Leong DJ, Laudier DM, Ruike T, Torina PJ, Zaidi M, Majeska RJ, Schaffler MB, Flatow EL, Sun HB. BMP-12 treatment of adult mesenchymal stem cells in vitro augments tendon-like tissue formation and defect repair in vivo.. PLoS One 2011 Mar 11;6(3):e17531.
    pmc: PMC3055887pubmed: 21412429doi: 10.1371/journal.pone.0017531google scholar: lookup
  21. Liu SL, Zhou YM, Tang DB, Zhou N, Zheng WW, Tang ZH, Duan CW, Zheng L, Chen J. LGR6 promotes osteogenesis by activating the Wnt/β-catenin signaling pathway.. Biochem Biophys Res Commun 2019 Oct 29;519(1):1-7.
    pubmed: 31500806doi: 10.1016/j.bbrc.2019.08.122google scholar: lookup
  22. Liu Y, Suen CW, Zhang JF, Li G. Current concepts on tenogenic differentiation and clinical applications.. J Orthop Translat 2017 Apr;9:28-42.
    pmc: PMC5822963pubmed: 29662797doi: 10.1016/j.jot.2017.02.005google scholar: lookup
  23. Lou J, Tu Y, Burns M, Silva MJ, Manske P. BMP-12 gene transfer augmentation of lacerated tendon repair.. J Orthop Res 2001 Nov;19(6):1199-202.
    pubmed: 11781024doi: 10.1016/s0736-0266(01)00042-0google scholar: lookup
  24. Minami I, Yamada K, Otsuji TG, Yamamoto T, Shen Y, Otsuka S, Kadota S, Morone N, Barve M, Asai Y, Tenkova-Heuser T, Heuser JE, Uesugi M, Aiba K, Nakatsuji N. A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions.. Cell Rep 2012 Nov 29;2(5):1448-60.
    pubmed: 23103164doi: 10.1016/j.celrep.2012.09.015google scholar: lookup
  25. Miyabara S, Yuda Y, Kasashima Y, Kuwano A, Arai K. Regulation of Tenomodulin Expression Via Wnt/β-catenin Signaling in Equine Bone Marrow-derived Mesenchymal Stem Cells.. J Equine Sci 2014;25(1):7-13.
    pmc: PMC4019198pubmed: 24834008doi: 10.1294/jes.25.7google scholar: lookup
  26. Murchison ND, Price BA, Conner DA, Keene DR, Olson EN, Tabin CJ, Schweitzer R. Regulation of tendon differentiation by scleraxis distinguishes force-transmitting tendons from muscle-anchoring tendons.. Development 2007 Jul;134(14):2697-708.
    pubmed: 17567668doi: 10.1242/dev.001933google scholar: lookup
  27. Murray SJ, Santangelo KS, Bertone AL. Evaluation of early cellular influences of bone morphogenetic proteins 12 and 2 on equine superficial digital flexor tenocytes and bone marrow-derived mesenchymal stem cells in vitro.. Am J Vet Res 2010 Jan;71(1):103-14.
    pmc: PMC4246500pubmed: 20043789doi: 10.2460/ajvr.71.1.103google scholar: lookup
  28. Nixon AJ, Dahlgren LA, Haupt JL, Yeager AE, Ward DL. Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis.. Am J Vet Res 2008 Jul;69(7):928-37.
    pubmed: 18593247doi: 10.2460/ajvr.69.7.928google scholar: lookup
  29. Norelli JB, Plaza DP, Stal DN, Varghese AM, Liang H, Grande DA. Tenogenically differentiated adipose-derived stem cells are effective in Achilles tendon repair in vivo.. J Tissue Eng 2018 Jan-Dec;9:2041731418811183.
    pmc: PMC6236638pubmed: 30542597doi: 10.1177/2041731418811183google scholar: lookup
  30. Patterson-Kane JC, Rich T. Achilles tendon injuries in elite athletes: lessons in pathophysiology from their equine counterparts.. ILAR J 2014;55(1):86-99.
    pubmed: 24936032doi: 10.1093/ilar/ilu004google scholar: lookup
  31. Shen H, Gelberman RH, Silva MJ, Sakiyama-Elbert SE, Thomopoulos S. BMP12 induces tenogenic differentiation of adipose-derived stromal cells.. PLoS One 2013;8(10):e77613.
    pmc: PMC3796462pubmed: 24155967doi: 10.1371/journal.pone.0077613google scholar: lookup
  32. Shojaee A, Parham A. Strategies of tenogenic differentiation of equine stem cells for tendon repair: current status and challenges.. Stem Cell Res Ther 2019 Jun 18;10(1):181.
    pmc: PMC6582602pubmed: 31215490doi: 10.1186/s13287-019-1291-0google scholar: lookup
  33. Shukunami C, Takimoto A, Nishizaki Y, Yoshimoto Y, Tanaka S, Miura S, Watanabe H, Sakuma T, Yamamoto T, Kondoh G, Hiraki Y. Scleraxis is a transcriptional activator that regulates the expression of Tenomodulin, a marker of mature tenocytes and ligamentocytes.. Sci Rep 2018 Feb 16;8(1):3155.
    pmc: PMC5816641pubmed: 29453333doi: 10.1038/s41598-018-21194-3google scholar: lookup
  34. Smith RK, Werling NJ, Dakin SG, Alam R, Goodship AE, Dudhia J. Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy.. PLoS One 2013;8(9):e75697.
    pmc: PMC3783421pubmed: 24086616doi: 10.1371/journal.pone.0075697google scholar: lookup
  35. Sun C, Lan W, Li B, Zuo R, Xing H, Liu M, Li J, Yao Y, Wu J, Tang Y, Liu H, Zhou Y. Glucose regulates tissue-specific chondro-osteogenic differentiation of human cartilage endplate stem cells via O-GlcNAcylation of Sox9 and Runx2.. Stem Cell Res Ther 2019 Nov 28;10(1):357.
    pmc: PMC6883626pubmed: 31779679doi: 10.1186/s13287-019-1440-5google scholar: lookup
  36. Tani S, Chung UI, Ohba S, Hojo H. Understanding paraxial mesoderm development and sclerotome specification for skeletal repair.. Exp Mol Med 2020 Aug;52(8):1166-1177.
    pmc: PMC8080658pubmed: 32788657doi: 10.1038/s12276-020-0482-1google scholar: lookup
  37. Tarafder S, Ricupero C, Minhas S, Yu RJ, Alex AD, Lee CH. A Combination of Oxo-M and 4-PPBP as a potential regenerative therapeutics for tendon injury.. Theranostics 2019;9(14):4241-4254.
    pmc: PMC6592164pubmed: 31281545doi: 10.7150/thno.35285google scholar: lookup
  38. Tesena P, Korchunjit W, Taylor J, Wongtawan T. Comparison of commercial RNA extraction kits and qPCR master mixes for studying gene expression in small biopsy tissue samples from the equine gastric epithelium.. J Equine Sci 2017;28(4):135-141.
    pmc: PMC5735310pubmed: 29270070doi: 10.1294/jes.28.135google scholar: lookup
  39. Thorpe CT, Clegg PD, Birch HL. A review of tendon injury: why is the equine superficial digital flexor tendon most at risk?. Equine Vet J 2010 Mar;42(2):174-80.
    pubmed: 20156256doi: 10.2746/042516409x480395google scholar: lookup
  40. Vandenberghe A, Broeckx SY, Beerts C, Seys B, Zimmerman M, Verweire I, Suls M, Spaas JH. Tenogenically Induced Allogeneic Mesenchymal Stem Cells for the Treatment of Proximal Suspensory Ligament Desmitis in a Horse.. Front Vet Sci 2015;2:49.
    pmc: PMC4672201pubmed: 26664976doi: 10.3389/fvets.2015.00049google scholar: lookup
  41. Wang Y, Tang H, He G, Shi Y, Kang X, Lyu J, Zhou M, Zhu M, Zhang J, Tang K. High Concentration of Aspirin Induces Apoptosis in Rat Tendon Stem Cells via Inhibition of the Wnt/β-Catenin Pathway.. Cell Physiol Biochem 2018;50(6):2046-2059.
    pubmed: 30415260doi: 10.1159/000495050google scholar: lookup
  42. Watchrarat K, Korchunjit W, Buranasinsup S, Taylor J, Ritruechai P, Wongtawan T. MEM α promotes cell proliferation and expression of bone marrow derived equine mesenchymal stem cell gene markers but depresses differentiation gene markers. J. Equine Vet. Sci. 2017;50:8–14.
  43. Yoshimoto Y, Takimoto A, Watanabe H, Hiraki Y, Kondoh G, Shukunami C. Scleraxis is required for maturation of tissue domains for proper integration of the musculoskeletal system.. Sci Rep 2017 Mar 22;7:45010.
    pmc: PMC5361204pubmed: 28327634doi: 10.1038/srep45010google scholar: lookup
  44. Yu Y, Bliss JP, Bruce WJ, Walsh WR. Bone morphogenetic proteins and Smad expression in ovine tendon-bone healing.. Arthroscopy 2007 Feb;23(2):205-10.
    pubmed: 17276229doi: 10.1016/j.arthro.2006.08.023google scholar: lookup
  45. Yuasa M, Yamada T, Taniyama T, Masaoka T, Xuetao W, Yoshii T, Horie M, Yasuda H, Uemura T, Okawa A, Sotome S. Dexamethasone enhances osteogenic differentiation of bone marrow- and muscle-derived stromal cells and augments ectopic bone formation induced by bone morphogenetic protein-2.. PLoS One 2015;10(2):e0116462.
    pmc: PMC4319911pubmed: 25659106doi: 10.1371/journal.pone.0116462google scholar: lookup

Citations

This article has been cited 1 times.
  1. Jiang L, Lu J, Chen Y, Lyu K, Long L, Wang X, Liu T, Li S. Mesenchymal stem cells: An efficient cell therapy for tendon repair (Review).. Int J Mol Med 2023 Aug;52(2).
    doi: 10.3892/ijmm.2023.5273pubmed: 37387410google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.